Monthly reporting for drug supply stirs debate

Published: 2007-10-16 06:58:00

Updated: 2007-10-16 06:58:00

The government's plan to strengthen the obligation of pharmaceutical wholesalers to report their drug supply on a monthly basis instead of on a quarterly basis has recently emerged as a thorny issue in the industry.

The ministry of Health and Welfare reaffirmed its determination to enact the m...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK